Business Daily
No Result
View All Result
Saturday, March 25, 2023
  • Login
  • Home
  • Business
  • World
  • Investment
  • House
Subscribe
Business Daily
  • Home
  • Business
  • World
  • Investment
  • House
No Result
View All Result
Business Daily
No Result
View All Result
Home Investment

Is it Still Worthy to Invest in Cross Country Healthcare (CCRN)?

by Smith
2022年9月7日
in Investment
0
152
SHARES
1.9k
VIEWS
Share on FacebookShare on Twitter

Rhizome Partners, an investment management firm, published its second-quarter 2022 investor letter – a copy of which can be downloaded here . For the second quarter of 2022, Rhizome Partners generated a net loss of 9.1% versus a 16.1% loss for the Standard & Poor’s 500 Index and a 14.7% loss for the National Association of Real Estate Investment Trusts (NAREIT) Index. During the quarter, the fund’s hedging efforts generated about 5.5% of gains. The hedging gains were the primary contributor to Rhizome’s outperformance in the S&P 500 and the NAREIT.  Go over the fund’s top 5 positions to have a glimpse of its finest picks for 2022.

In its Q2 2022 investor letter, Rhizome Partners mentioned Cross Country Healthcare, Inc. (NASDAQ:

CCRN

) and explained its insights for the company. Founded in 1986, Cross Country Healthcare, Inc. (NASDAQ:CCRN) is a Boca Raton, Florida-based employment agency company with a $971.8 million market capitalization. Cross Country Healthcare, Inc. (NASDAQ:CCRN) delivered a -8.43% return since the beginning of the year, while its 12-month returns are up by 16.87%. The stock closed at $25.42 per share on August 30, 2022.

Here is what Rhizome Partners has to say about Cross Country Healthcare, Inc. (NASDAQ:CCRN) in its Q2 2022 investor letter:

“Our smaller positions in both HireQuest and Cross Country Healthcare are trading around 10 times normalized P/FCF multiples. Both companies have long growth runways and are led by talented CEOs. The ongoing maintenance capital expenditures of both companies are minimal. We keep looking for ways to disprove both investment theses and have a hard time coming up with valid reasons. Investors are concerned that Cross Country Healthcare is a Covid beneficiary and will eventually revert to its pre-Covid performances. But the bulk of the operational improvements that increased EBITDA margin from low single digits to high single digits during Covid is structural and permanent. Both companies are ideal candidates to add to if they continue to sell off.”

Our calculations show that Cross Country Healthcare, Inc. (NASDAQ:CCRN) fell short and didn’t make it on our list of the

30 Most Popular Stocks Among Hedge Funds

. Cross Country Healthcare, Inc. (NASDAQ:CCRN) was in 15 hedge fund portfolios at the end of the second quarter of 2022, compared to 22 funds in the previous quarter. Cross Country Healthcare, Inc. (NASDAQ:CCRN) delivered a 44.02% return in the past 3 months.

In June 2022, we also shared another hedge fund’s views on Cross Country Healthcare, Inc. (NASDAQ:CCRN) in

another article

. You can find other investor letters from hedge funds and prominent investors on our

hedge fund investor letters 2022 Q2

page.

Disclosure: None. This article is originally published at Insider Monkey .

Tags: fund investmentinvestment

Have a look

Recent Articles

  • Is it Wise to Retain Jones Lang LaSalle (JLL) Stock for Now?
  • Stock market news live updates: Stocks slide into long weekend after forfeiting post-jobs report gains
  • ETH leads crypto market cap above $1 trillion as markets rally after jobs data
  • The Power Play by The Market Herald Releases a New Interview with Giga Metals Discussing Their Latest News
  • The stock market could still rally to new highs by the end of the year as plunging oil prices help tame inflation, Fundstrat’s Tom Lee says

Categories

  • Business
  • House
  • Investment
  • World

Site Navigation

  • About
  • Contact
  • cookie-policy
Business Daily

Share the latest business news every day.

No Result
View All Result
  • Home
  • Business
  • World
  • Investment
  • House

© 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In